News Cancer genomic tests often aren’t done to guideline; germline data presents unique issuesMarch 3, 2020SANTA CLARA, Calif. – Just as it does with treatments, the… https://myoncopath.com/wp-content/uploads/2020/03/Cancer-and-Cancer-immunotherapy.png 900 1200 Jaret Cohen https://myoncopath.com/wp-content/uploads/2017/07/myoncopath_test_3.svg Jaret Cohen2020-03-03 23:32:502020-03-24 19:48:04Cancer genomic tests often aren’t done to guideline; germline data presents unique issues